A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS
Clinical trial NCT06715241 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06715241
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-11
- Primary completion
- 2030-12-31
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.